Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study
Reducing the use of PPIs and antibiotics and prioritizing more effective treatments against CDI could improve the recurrence rates of this infection.
Authors
- Breno T. Lino
- Laura Molina‐Porcel (ORCID: https://orcid.org/0000-0003-4068-8578)
- Verónica Perea (ORCID: https://orcid.org/0000-0001-8104-7326)
- Juan Arévalo‐Serrano (ORCID: https://orcid.org/0000-0003-2563-7860)
- Coral Arévalo-Cañas (ORCID: https://orcid.org/0000-0003-0197-3237)
- Vicente Sánchez (ORCID: https://orcid.org/0000-0002-1698-2665)
- Andrés González García (ORCID: https://orcid.org/0000-0002-7367-9523)
- María Victoria Irigoyen
- Clara Paz (ORCID: https://orcid.org/0000-0003-1106-9567)
- Lucas López Requejo
- Elisa Brosina de Leon
- J.M. Barbero Allende
- S Luis Coronado
- Josep Pastor Cano
- N Fernández-Domingo
- P Lanchares
- M Ortolá
- A Lizasoain
- L Cañivano
- A Olmo-Ruiloba
- K Jauregi
Institutions
- Hospital Universitario Príncipe de Asturias (ES)
Publication Details
- Journal
- Revista Española de Quimioterapia
- Published
- 2024-11-26
- DOI
- https://doi.org/10.37201/req/086.2024
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00